Search
for
Sort by
Research 211–240 of 1000+
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Therapeutic Potentiality of Celtis choseniana Nakai on Androgenic Alopecia through Repression of Androgen Action and Modulation of Wnt/β-catenin Signaling
- The pattern and profile of alopecia areata in Singapore – a study of 219 Asians
- Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia
- <i>Morinda pubescens</i> J.E. Smith (<i>Morinda tinctoria</i> Roxb.) Fruit Extract Accelerates Wound Healing in Rats
- A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low‐level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow‐up based on clinical studies
- Chronic circadian misalignment is a risk factor for hair growth impairment
- The dual-action monophenolic antioxidant TS-13 accelerates hair coat restoration in a mouse model of chemotherapy-induced alopecia
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- Observing the clinical efficacy of combined serum microneedle therapy for moderate to severe androgenetic alopecia in scalp repair
- 1311 Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia
- Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
- Clinical observered human dermal papilla cells conditioned medium treated androgenetic alopecia
- Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: A retrospective case series
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology
- Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review
- Emerging drugs for the treatment of alopecia areata
- Topical minoxidil in alopecia areata: a double-blind trial
- Excimer lamp as an effective alternative treatment for severe alopecia areata
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Randomized Study to Evaluate the Efficacy of Platelet Rich Plasma, Intralesional Triamcinolone Acetonide and Intralesional Normal Saline in Moderate to Severe Alopecia Areata
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Efficacy Of Hormonal Therapy Vs Non-Hormonal Therapy in Female Pattern Hair Loss (FPHL): A Systematic Review
- Comparison of the Efficacy of Topical Methotrexate 1% gel Versus Topical Betamethasone Dipropionate 0.05% Lotion in the Treatment of Localized Scalp Alopecia Areata in a Tertiary Care Institute of Central India: A Randomized Control Trial
- O04 Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation
- Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
- The Effectiveness and Safety of Three Treatment Regimens of Topical Minoxidil 5.0%, Betamethasone 0.064% w/w, and Castor and Jojoba Oils for Alopecia Areata: A Multicenter Cohort Study